Receive Text Messages

If you would like to receive a text message reminder on the day of the event, please enter your phone number and click 'Submit':

Ask a Question

Please submit questions that you would like addressed during the event (You may do this multiple times):

An Expert Discussion on MDS: Current and Future Personalized Management Approaches

Friday, 12/9/2022 11:30 AM - 1:30 PM CT

Webinar

Register for this event

Agenda
  • Welcome and Introductions
  • Risk Stratification in MDS Using the Most Up-to-Date Risk Scoring Systems
  • Managing Anemia in Very Low–Risk, Low-Risk, or Intermediate-Risk MDS
  • Novel Therapeutic Approaches for the Treatment of Lower-Risk MDS
  • Latest Guidance on the Treatment of Higher-Risk MDS and Managing Relapsed/Refractory MDS
  • Final Thoughts
  • Audience Question and Answer

Click here to view additional event information.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge and competence of learners on current and emerging treatment options and the latest clinical data on lower-risk, intermediate-risk, and high-risk MDS.

Target Audience
This educational program is intended for medical oncologists and other healthcare professionals who treat patients with MDS.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate novel therapeutic options for managing MDS-related symptoms, which may include anemia, cytopenia, thrombocytopenia, and/or neutropenia
  • Plan therapeutic strategies using available and emerging treatment options for patients with lower-, intermediate-, or high-risk MDS based on expert recommendations and available clinical evidence
  • Plan evidence-based therapeutic strategies for patients with relapsed/refractory disease
  • Identify patients eligible for enrollment on clinical trials investigating novel therapeutic approaches for treating and managing MDS
Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Clinical Care Options, LLC Logo

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supported by educational grants from

Bristol Myers Squibb
Geron Corporation
Karyopharm Therapeutics Inc.
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings